Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms

202122 citationsJournal Articlebronze Open Access

Authors

Joris Guyon · Université de Bordeaux

Amandine Gouverneur · Université de Bordeaux

Sandy Maumus‐Robert · Bordeaux Population Health

Xavier Bérard · Université de Bordeaux

Alexandre Pariente · Université de Bordeaux

Andréas Bikfalvi · Angiogenesis and Cancer Microenvironment Laboratory

Pernelle Noïze

Abstract

This pharmacovigilance study uses data from the World Health Organization database of adverse drug reactions to examine the association of antiangiogenic drugs with artery dissections or aneurysms among patients receiving antiangiogenic drugs for the treatment of cancer.

Topics & Keywords

Renal and Vascular Pathologies Renal cell carcinoma treatment Neurological Complications and Syndromes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 7, Issue 5, pp. 775-775

DOI: 10.1001/jamaoncol.2021.0210

Field-Weighted Citation Impact: 2.05